Panther Fusion® Respiratory Assays

The Panther Fusion Respiratory assays are the premier set of assays on the Panther Fusion system. You can provide truly personalized syndromic respiratory testing with qualitative detection and differentiation of the most common respiratory viruses from a single patient sample. Each Panther Fusion Respiratory assay can be processed independently or simultaneously with other Panther Fusion and Aptima® assays.
The Panther Fusion Flu A/B/RSV, Panther Fusion Paraflu and Panther Fusion AdV/hMPV/RV assays comprise the IVD respiratory testing menu on the fully automated Panther Fusion system. Each is a multiplex, real-time PCR in vitro diagnostic test. These assays can be run on nasopharyngeal (NP) swab specimens obtained from individuals exhibiting signs and symptoms of a respiratory tract infection.1-3  Additionally, the Panther Fusion SARS-CoV-2 assay has received Emergency Use Authorization for the detection of SARS-CoV-2 from nasopharyngeal, nasal, mid-turbinate and oropharyngeal swab specimens, nasopharyngeal wash/aspirate or nasal wash, and lower respiratory tract specimens.4


Personalized Respiratory Testing

The Panther Fusion assays provide the flexibility to run patient-specific targets, allowing for personalized patient testing and better cost control in your lab.
  • The Panther Fusion Flu A/B/RSV assay – Qualitative detection and differentiation of influenza A virus, influenza B virus and respiratory syncytial virus.1
  • The Panther Fusion AdV/hMPV/RV assay – Qualitative detection and differentiation of adenovirus, human metapneumovirus and rhinovirus.2
  • The Panther Fusion Paraflu assay – Qualitative detection and differentiation of parainfluenza1 virus, parainfluenza2 virus, parainfluenza3 virus and parainfluenza4 virus.3
  • The Hologic® SARS-CoV-2 assays* – Qualitative detection of SARS-CoV-2 virus.4

Additionally, when you leverage the power of Panther Fusion, your lab can:

  • Run more efficiently with full automation from sample-to-result.
  • Receive easy-to-interpret results.
  • Personalize syndromic respiratory testing by processing multiple assays from a single specimen.
  • Control costs by running only the required assays and reduce expense of unnecessary tests.
  • Eliminate the need for reagent preparation with Panther Fusion’s ready-to-use format.
  • Reduce waste with 60 day on-board reagent stability.
  • Consolidate menu onto a single, fully automated platform with the ability to run both Aptima and Panther Fusion assays alongside each other at the same time.


Curabitur accumsan auctor ipsum, eget aliquam tellus dignissim id. Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Sed vehicula scelerisque lacus id ultrices. Nullam vestibulum pharetra orci vel venenatis. Proin in pulvinar lorem, sed tempor felis. Cras tincidunt non felis imperdiet lobortis. Nulla nec nisl tempor, tincidunt lectus quis, tincidunt leo. Quisque laoreet ac velit fringilla tempor. Nullam a sollicitudin tellus. Curabitur et nulla quis diam porttitor tempor sed eu magna. Sed magna magna, fringilla vel luctus at, eleifend vitae risus. Fusce maximus pellentesque risus at ornare. Ut fermentum semper elit.

More Products

Panther Fusion® Open Access™

Laboratory Developed Tests (LDTs) are an essential part of diagnostics. Patients with certain medical conditions depend on these in-house developed tests when other options are not available. Save time and increase efficiency by consolidating your LDTs and IVD assays on the fully automated, sample-to-result, Panther Fusion system using the Open Access™ functionality.

Aptima® Vaginal Health

The Aptima vaginitis panel from Hologic consists of molecular nucleic acid amplification tests (NAAT) to aid in the detection of vaginosis and vaginitis. Our assays detect the three most common causes of infectious vaginitis: bacterial vaginosis, candida vaginitis and trichomoniasis.

Aptima® HIV-1 Quant Dx Assay

Dual-claim assay to confirm HIV-1 infection and measure viral load.

Aptima® Herpes Simplex 1 & 2 assay

Globally, over 4.1 billion people are infected with HSV-1 and HSV-2 and the signs and symptoms can overlap.1 It is only through laboratory tests that these subtypes can be differentiated, which is important for managing herpes infections and identifying the risk of transmission to neonates and among sex partners.2,3